• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards

Sarepta Therapeutics

Completing steps towards success checkmark on cubes symbolizing progress
Biotech

Sarepta's big bet on Arrowhead's siRNA assets yields early data

Sarepta shared clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead’'s pipeline.
Nick Paul Taylor Mar 25, 2026 9:35am
Parachute over a mountain in Switzerland

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Feb 27, 2026 8:30am
sarepta building
Favicon Fierce Pharma

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Feb 26, 2026 11:30am
Rotten tomato splat fruit

Fierce Biotech's Rotten Tomatoes of 2025

Dec 16, 2025 4:30am
Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes

Dyne readies FDA push after DMD exon 51 med excels in trial

Dec 8, 2025 10:50am
Completing steps towards success checkmark on cubes symbolizing progress

Sarepta shares safety update on DM1 RNA med

Nov 24, 2025 4:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings